Acciones Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Acciones
REKA
IL0010810096
Farmacéuticos
Ventas 2022 | 292 M 76,8 M 71,83 M | Ventas 2023 | 322 M 84,49 M 79,02 M | Capitalización | 169 M 44,32 M 41,45 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -2 M -525 mil -491 mil | Resultado Neto 2023 | -6 M -1,58 M -1,47 M | VE / Ventas 2022 | 1,1 x |
Deuda neta 2022 | 145 M 38,2 M 35,72 M | Deuda neta 2023 | 166 M 43,72 M 40,89 M | VE / Ventas 2023 | 1,04 x |
P/E ratio 2022 |
-85,5
x | P/E ratio 2023 |
-24,2
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 17,36 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,35 % | 71,39 mil M | |
+2,39 % | 25,1 mil M | |
+5,38 % | 8590,68 M | |
+6,69 % | 8187,39 M | |
-20,96 % | 7914,57 M | |
+0,49 % | 4540,5 M | |
+17,12 % | 4313,82 M | |
-3,38 % | 3930,42 M | |
-2,61 % | 3859,77 M |